Company page

Canopus Biopharma, Inc.

Canopus Biopharma, Inc. (CBIA) is a public company based in the United States with a market capitalization of approximately $4.55 billion. The company is focused on biopharmaceuticals and is listed on the American stock market. Investors can find relevant information about its operations and performance on its dedicated public company page.